Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), bought 12,298 shares at $7.48 ($84K) on 2023-03-06, disclosed to the SEC on 2023-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.48 | 3,000 | $22K | 26.7% |
| 2 | $7.04 | 2,000 | $14K | 16.7% |
| 3 | $6.50 | 1,000 | $7K | 7.7% |
| 4 | $6.52 | 6,298 | $41K | 48.8% |
| Total | $6.84 avg | 12,298 | $84K | 100% |
| Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |
| NVAX | SELL | 2021-11-24 | $2.5M | — | Filing → |